AI-Powered Vaccine Shrinks Tumors in Dog with Incurable Cancer

In a remarkable case highlighting the potential of artificial intelligence in veterinary medicine, an Australian tech entrepreneur developed a personalized mRNA cancer vaccine for his dog, Rosie, after conventional treatments failed. The vaccine, created with the aid of ChatGPT and Google’s DeepMind AlphaFold, has led to significant tumor reduction and improved quality of life for the seven-year-old staffy-cross-shar pei.

Rosie’s Battle with Mast Cell Cancer

Rosie was diagnosed with Mast Cell Cancer, a relatively common but often incurable cancer in dogs. Despite undergoing multiple surgeries, chemotherapy, and immunotherapy, the tumors persisted, and her condition worsened. Veterinarians estimated she had between one and six months to live [1].

Harnessing AI for a Personalized Approach

Determined to save his beloved companion, Paul Conyngham, an AI consultant and entrepreneur, turned to artificial intelligence. He utilized ChatGPT to formulate a plan and then collaborated with The University of New South Wales Ramaciotti Centre for Genomics to sequence Rosie’s DNA [2]. The genomic sequencing cost approximately $3,000 Australian dollars [3].

From Data to Vaccine: A Collaborative Effort

Conyngham used AlphaFold to identify mutated proteins that could serve as targets for treatment. When a suitable immunotherapy drug proved unavailable, he connected with nanomedicine pioneer Pall Thordarson, director of UNSW’s RNA Institute. Thordarson leveraged Conyngham’s data to design a custom mRNA vaccine in under two months [3]. This marks the first instance of a personalized cancer vaccine specifically designed for a dog [3].

Positive Results and Future Implications

Rosie received her first vaccine dose in December and a booster in February. The treatment has resulted in a dramatic reduction in most of her tumors, and her overall health has significantly improved. While some tumors haven’t fully responded, Rosie has regained energy and vitality, even chasing rabbits at the dog park [3].

Thordarson believes Rosie’s case demonstrates the potential to “democratize” cancer vaccine design through technology and suggests this approach could ultimately be applied to human cancer treatment [3]. He emphasized that personalized medicine, delivered in a timely manner with mRNA technology, can be highly effective.

A Glimmer of Hope

While acknowledging that a complete cure isn’t guaranteed, Conyngham is optimistic about the treatment’s impact on Rosie’s quality of life and lifespan. He views the success as a testament to the power of combining AI with scientific expertise to tackle challenging medical cases [3].